Titre:
  • Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
Auteur:Marechal, Raphaël; Mackey, John R; Lai, Raymond; Demetter, Pieter; Peeters, Marc; Polus, Marc; Cass, Carol E; Salmon, Isabelle; Devière, Jacques; Van Laethem, Jean-Luc
Informations sur la publication:Cancer, 116, 22, page (5200-5206)
Statut de publication:Publié, 2010-11
Sujet CREF:Anatomopathologie
Médecine pathologie humaine
Mots-clés:cancer
deoxycytidine kinase
gemcitabine
pancreas
surgery
MeSH keywords:Adenocarcinoma -- drug therapy -- enzymology -- surgery
Adult
Aged
Aged, 80 and over
Chemotherapy, Adjuvant
Combined Modality Therapy
Deoxycytidine -- analogs & derivatives -- therapeutic use
Deoxycytidine Kinase -- metabolism
Disease-Free Survival
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy -- enzymology -- metabolism -- mortality -- surgery
Treatment Outcome
Note générale:Journal Article
Research Support, Non-U.S. Gov't
FLWIN
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0008-543X
info:doi/10.1002/cncr.25303
info:scp/78449295201
info:pmid/20669326